Indivior to release Q3 2026 financial results on October 29, 2026

Indivior Pharmaceuticals will announce its third quarter 2026 financial results on October 29, 2026, at 7:00 a.m. U.S. EDT. The results will be available on the company's website. Indivior specializes in long-acting injectable treatments for opioid use disorder, focusing on advancing treatment and understanding of this chronic brain disease. This earnings release will provide investors insight into the company's ongoing performance and progress in addiction medicine.

As Indivior prepares to release its third quarter 2026 financial results on October 29, investors on Pluang are seeing the stock trade at USD 33.22 as of October 19, 2026, 19:42 WIB. The share price has risen by 2.37% in the past day, reflecting active interest ahead of the earnings announcement. Indivior's market capitalization stands at $3.83 billion, with a 52-week trading range between $24.09 and $41.83.